ConneyA. H.: Drug Metabolism and Therapeutics. New Eng. J. Med.280: 653–660, 1969.
2.
SternL.KhannaN. N.LevyG.YaffeS. J.: Effect of Phenobarbital on Hyperbilirubinemia and Glucuronide Formation in Newborns. Amer. J. Dis. Child.120: 26–31, 1970.
3.
HunterJ.ThompsonR. P. H.RakeM. O.WilliamsR.: Controlled Trial of Phethabarbital, a Non-hypnotic Barbiturate, in Unconjugated Hyperbilirubinemia. Brit. Med. J.2: 497–499, 1971.
4.
EspelinD. E.DoneA. K.: Amphetamine Poisoning. Effectiveness of Chlorpromazine. New Eng. J. Med.278: 1361–1365, 1968.
5.
LembergerL.WittE. O.DavisJ. M.KopinI. J.: The Effects of Haloperidol and Chlorpromazine on Amphetamine Metabolism and Amphetamine Stereotype Behavior in the Rat. J. Pharmacol. Exp. Ther.174: 428–433, 1970.
6.
ElionG. B.CallahanS.NathanH.BieberS.RundlesR. W.HitchingsG. H.: Potentiation by Inhibition of Drug Degradation: 6-Substituted Purines and Xanthine Oxidase. Biochem. Pharmacol.12: 85–93, 1963.
7.
WhartonR. N.PerelJ. M.DaytonP. G.MalitzS.: A Potential Clinical Use for Methylphenidate with Tricyclic Antidepressants. Amer. J. Psychiat.127: 1619–1625, 1971.
8.
GoodwinF. K.BrodieH. K. H.MurphyD. L.BunneyW. E.Jr.: Administration of a Peripheral Decarboxylase Inhibitor with 1-Dopa in Depressed Patients. Lancet1: 908–911, 1970.
9.
VajdaF. J. E.PrimeasR. J.LovellR. R. H.: Interaction Between Phenytoin and the Benzodiazepines. Brit. Med. J.1: 346, 1971.
10.
BrodieB. B.: Displacement of One Drug by Another from Carrier or Receptor Sites. Proc. Roy. Soc. Med.58: 946–955, 1965.
11.
WilsonI. C.PrangeA. J.McClaneT. K.RabonA. M.LiptonM. A.: Thyroid-Hormone Enhancement of Imipramine in Nonretarded Depressions. New Eng. J. Med.282: 1063–1067, 1970.
